Previous studies have shown that anti-colorectal cancer mAbs with plant-specific glycostructures had similar in vitro interactions of Fc and the Fc Receptor I (CD64) to their parental mAbM[7], [35] and in vivo anti-tumor activity [36]. Here, FCGR1A is linked to neoplasm.